NCT02909595

Brief Summary

Endoscopic bile duct stone (BDS) removal is a well-established treatment; however, the preference for basket or balloon catheters for extraction is operator-dependent It is reported that complete endoscopic treatment with a single catheter is more likely when choosing a balloon catheter over a basket catheter for extraction of BDSs≤10mm. However, a study comparing the two catheter types in patients with periampullary diverticulum has not been performed, and there is no strong basis on which to recommend the balloon catheter as a first-line stone removal device. The investigators therefore conducted a multicenter prospective randomized trial to compare catheter performance in patients with periampullary diverticulum.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

September 10, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 21, 2016

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

December 14, 2016

Status Verified

September 1, 2016

Enrollment Period

2 years

First QC Date

September 10, 2016

Last Update Submit

December 13, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint is the rate of complete clearance of the duct in two groups.

    It has a contrast-injection hole above the balloon for the performance of balloon occlusion cholangiography (BOC). For balloon stone extraction, clearance was confirmed if no residual stones remained after the final BOC and balloon sweep. For basket stone extraction, duct clearance by the basket catheter was judged to have been completed when no filling defect was found. Complete clearance of the duct by the basket catheter was defined as no filling defect (other than air) on BOC after a balloon sweep.

    The primary end point was the rate of complete removals of stones within 10 min.

Secondary Outcomes (1)

  • Secondary endpoints is the rate of adverse events such as perforation, pancreatitis,cholangitis,hyperamylasemia and bleeding.

    Secondary endpoints is the rate of adverse events at 24 h after ERCP.

Study Arms (2)

Balloon catheter group

EXPERIMENTAL

Bile duct stones extraction was carried out with a balloon catheter.

Device: Balloon catheter

Basket catheter group

ACTIVE COMPARATOR

Bile duct stones extraction was carried out with a basket catheter.

Device: Basket catheter

Interventions

Balloon stone extraction was carried out with a balloon catheter \[Extractor Pro RX \[M00547000, M00547010, or M00547020\]; Boston Scientific,Shang hai,China). The Extractor Pro has multiple sizes (9-12, 12-15, and 15-18mm), the choice being made on the basis of the CBD diameter. It has a contrast-injection hole above the balloon for the performance of balloon occlusion cholangiography (BOC).

Balloon catheter group

Basket stone extraction was performed with a basket catheter (Flower Basket V \[FG-V435P or FG-V425PR\]; Olympus Corp., Shang hai,China).

Basket catheter group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females, age \> 18 years.
  • BDSs of diameter ≤10mm, which could be extracted using a standard balloon or basket catheter without mechanical lithotripsy, and a common bile duct (CBD) diameter ≤15mm.
  • Signed inform consent form and agreed to follow-up on time

You may not qualify if:

  • Medical or psychological condition that would not permit the patient to complete the study or sign the informed consent.
  • Patients involved in other study within 60 days.
  • biliary stricture
  • Billroth II or Roux-en-Y anatomy
  • Acute pancreatitis.
  • a history of previous ERCP
  • pregnant or breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of General Surgery, Anhui Provincial Hospital Affiliated with Anhui Medical University

Hefei, Anhui, 230001, China

Location

MeSH Terms

Conditions

Gallstones

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Shao Feng, MD

    Department of General Surgery, Anhui Provincial Hospital Affiliated with Anhui Medical University

    PRINCIPAL INVESTIGATOR
  • Wei Qi, MD

    No.2 of HeFei Hospital Affiliated Anhui Medical College

    PRINCIPAL INVESTIGATOR
  • YongQiang Jiang, MD

    Dong fang Hospital Affiliated Anhui University Of Science & Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2016

First Posted

September 21, 2016

Study Start

November 1, 2014

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

December 14, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share

Locations